Newsmeme!
Discover News you didn't know existed
Hypotension
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Cardioxyl Pharmaceuticals Initiates Phase I/IIa Study in Heart Failure
Published July 1, 2009, 5:50 am, Marketwire
Study to Evaluate the Safety and Tolerability of Lead Candidate, CXL-1020, in the Treatment of Cardiovascular Disease
Training Course for Propofol Administration Available Nationally
Published June 30, 2009, 5:33 pm, dBusinessNews.com
Medical News USA / Canada: Conscious Sedation Consulting announces the development of a course to educate non-anesthesia physicians and nurses in the administration of propofol.
FDA Approves Feraheme to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
Published June 30, 2009, 1:44 pm, Business Wire via Yahoo! Finance
LEXINGTON, Mass.----AMAG Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted marketing approval for Feraheme™ Injection for intravenous use as an iron replacement therapy for the treatment of iron deficiency anemia in adult patients with chronic kidney disease.
• July 2009 FEATURE ARTICLES •
Published June 29, 2009, 8:37 am, Health Management Technology
The mandated switch to the new International Classification of Diseases version 10 (ICD-10-CM) is scheduled for 2013, and should signal a move to improved patient safety due to the greater detail of the new codes.
Protox to present benign prostatic hyperplasia data at Canadian Urology Conference
Published June 29, 2009, 4:00 am, CNW Group via Yahoo! Finance
Protox Therapeutics Inc. , a leader in the development of receptor targeted fusion proteins, today announced that data from their open label Phase 2 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia , will be presented this afternoon at the 64th Annual Meeting of the Canadian Urological Association .
European Scientific Committee Positive Recommendation From For A New Once Daily Mirapexin(R) Formulation For The ...
Published June 28, 2009, 4:05 am, Medical News Today
Boehringer Ingelheim announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending the approval of a once daily formulation for Mirapexin®/ Sifrol® (pramipexole), in all countries of the European Union, Norway, Iceland and Liechtenstein.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |